Who owns Quest Diagnostics (DGX)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Quest Diagnostics (DGX) in their latest 13F filing, with $818.6M between them. Christopher Davis gives it the most weight: 1.34% of the reported portfolio. In their latest reported quarter, Jeremy Grantham (co-founder) added; Christopher Davis and Pat English reduced.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Jeremy Grantham (co-founder), $449.9M
- Largest weight
- Christopher Davis, 1.34%of their portfolio
- Combined value
- $818.6M
- Bought last quarter
- 1
- Sold last quarter
- 2
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Christopher DavisDavis Advisors | 1.34% | $309M | 1.33M | ▼ Reduced 15% | −229.91K | Q3 2026 |
| 2 | Jeremy Grantham (co-founder)GMO (Grantham, Mayo, Van Otterloo) | 0.97% | $449.9M | 1.93M | ▲ Added 2.2% | +42.11K | Q3 2026 |
| 3 | Pat EnglishFiduciary Management (FMI) | 0.91% | $59.8M | 256.37K | ▼ Reduced 47% | −227.16K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 3 | 3.51M | $818.6M | 1 | 2 |
| Q2 2026 | 157 | 3 | 3.93M | $832.5M | 1 | 2 |
| Q1 2026 | 157 | 3 | 4.22M | $827.4M | 2 | 1 |
| Q4 2025 | 157 | 4 | 4.48M | $776.9M | 3 | 1 |
| Q3 2025 | 157 | 4 | 4.27M | $814.5M | 2 | 3 |
| Q2 2025 | 157 | 3 | 4.29M | $770.2M | 0 | 4 |
| Q1 2025 | 156 | 4 | 5.77M | $975.7M | 0 | 5 |
| Q4 2024 | 156 | 4 | 6.27M | $946.4M | 1 | 4 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Jeremy Grantham (co-founder) | 1.93M | 1.89M | 1.88M | 1.82M | 1.75M | 1.75M | 2.01M | 2.27M |
| Christopher Davis | 1.33M | 1.56M | 1.62M | 1.59M | 1.36M | 1.35M | 2.39M | 2.4M |
| Pat English | 256.37K | 483.56K | 720.99K | 1.05M | 1.15M | 1.19M | 1.25M | 1.3M |
| Lee Ainslie | · | — | — | 23.9K | 18.18K | — | — | — |
| Sarah Ketterer | — | — | — | — | — | — | 120.4K | 304.48K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own DGX?
In their latest 13F filings: Christopher Davis (1.34% of the portfolio, $309M), Jeremy Grantham (co-founder) (0.97% of the portfolio, $449.9M), Pat English (0.91% of the portfolio, $59.8M).
Who bought DGX last quarter?
Jeremy Grantham (co-founder) (added 2.2%). “Last quarter” is each investor's latest reported quarter.
Who sold DGX last quarter?
Reduced: Christopher Davis (15% fewer shares), Pat English (47% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Quest Diagnostics (DGX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/DGX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to DGX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.